SU5416 in Treating Patients With Malignant Mesothelioma

Conditions: Malignant Mesothelioma
Start Date: August 1, 2000
Phase: Phase II
Status: Completed
NCT ID: NCT00006014
Study Type: Interventional
Intervention: Drug: semaxanib
Study Design: Treatment
Results: No Results Available
Sponsors: University of Chicago/National Cancer Institute (NCI)
Ages: Adult/Senior
Enrollment: 0
Funded By: OTHER/NIH
First Received: July 5, 2000
End Date: January 1, 1900
Last Updated: February 26, 2009
Last Verified: February 1, 2009

Search for asbestos exposure sites and asbestos companies in all 50 states.